RIPK3 and cervical carcinoma: Aim of this study was to analyze the expression of RIPK1, RIPK3, and pMLKL in cervical carcinoma patient tissue and to correlate their expression with clinical parameters, overall survival (OS) and progression-free survival (PFS).